METOPROLOL

METOPROLOL was reported 275108 times

METOPROLOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRASH SYNDROME 616 0.4387
1 EJECTION FRACTION 231 0.3976
2 SENSITISATION 252 0.3320
3 NEPHROGENIC ANAEMIA 954 0.2057
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 214 0.2015
5 HYPERPARATHYROIDISM SECONDARY 501 0.1998
6 PRODUCT MONITORING ERROR 276 0.1910
7 POLYCYSTIC OVARIES 250 0.1611
8 HYPERTENSIVE EMERGENCY 158 0.1340
9 EJECTION FRACTION ABNORMAL 162 0.1321
10 REBOUND ACID HYPERSECRETION 393 0.1298
11 END STAGE RENAL DISEASE 2058 0.1127
12 SYSTEMIC INFECTION 157 0.0946
13 HAEMORRHAGIC ANAEMIA 396 0.0900
14 ESSENTIAL HYPERTENSION 158 0.0862
15 ATRIAL FLUTTER 616 0.0771
16 RHINITIS ALLERGIC 323 0.0725
17 ATRIAL FIBRILLATION 6931 0.0711
18 CHRONIC KIDNEY DISEASE 5391 0.0709
19 ATRIOVENTRICULAR BLOCK FIRST DEGREE 305 0.0703
20 SUSPECTED SUICIDE 322 0.0686
21 BLOOD PRESSURE DIASTOLIC ABNORMAL 174 0.0683
22 CORONARY ARTERY STENOSIS 340 0.0675
23 CORONARY ARTERY OCCLUSION 908 0.0661
24 TACHYARRHYTHMIA 165 0.0661
25 NEPHROGENIC SYSTEMIC FIBROSIS 198 0.0655
26 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 568 0.0642
27 ORTHOPNOEA 204 0.0640
28 ANGINA UNSTABLE 415 0.0638
29 AORTIC STENOSIS 222 0.0637
30 HEART VALVE INCOMPETENCE 181 0.0631
31 BRADYCARDIA 3252 0.0613
32 SINUS BRADYCARDIA 592 0.0612
33 DIASTOLIC DYSFUNCTION 187 0.0605
34 CARDIAC FAILURE CHRONIC 255 0.0598
35 CORONARY ARTERY DISEASE 1805 0.0595
36 LOWER GASTROINTESTINAL HAEMORRHAGE 437 0.0591
37 ISCHAEMIC CARDIOMYOPATHY 172 0.0560
38 VENTRICULAR HYPOKINESIA 180 0.0560
39 ATRIOVENTRICULAR BLOCK COMPLETE 368 0.0549
40 FIBROSIS 169 0.0549
41 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 224 0.0548
42 ATRIOVENTRICULAR BLOCK 424 0.0548
43 CARDIOGENIC SHOCK 776 0.0540
44 LEFT VENTRICULAR HYPERTROPHY 231 0.0539
45 MITRAL VALVE INCOMPETENCE 604 0.0533
46 ACUTE MYOCARDIAL INFARCTION 1564 0.0530
47 CORONARY ARTERIAL STENT INSERTION 268 0.0528
48 RENAL INJURY 1539 0.0518
49 ARTERIOSCLEROSIS CORONARY ARTERY 342 0.0516
50 VENTRICULAR TACHYCARDIA 849 0.0514
51 AORTIC VALVE INCOMPETENCE 218 0.0512
52 HYPOVOLAEMIA 299 0.0511
53 CORONARY ARTERY BYPASS 293 0.0509
54 LEFT VENTRICULAR FAILURE 174 0.0505
55 SUPRAVENTRICULAR TACHYCARDIA 479 0.0500
56 ACUTE CORONARY SYNDROME 414 0.0499
57 BUNDLE BRANCH BLOCK LEFT 209 0.0492
58 SUPRAVENTRICULAR EXTRASYSTOLES 166 0.0491
59 PROSTATOMEGALY 193 0.0491
60 GOUT 879 0.0489
61 CARDIAC VALVE DISEASE 280 0.0489
62 HEART RATE DECREASED 1705 0.0485
63 CARDIAC FAILURE CONGESTIVE 3888 0.0484
64 INTERNATIONAL NORMALISED RATIO DECREASED 195 0.0481
65 UPPER GASTROINTESTINAL HAEMORRHAGE 808 0.0480
66 TRICUSPID VALVE INCOMPETENCE 375 0.0472
67 HAEMORRHOIDAL HAEMORRHAGE 230 0.0471
68 VENTRICULAR EXTRASYSTOLES 489 0.0470
69 TROPONIN INCREASED 358 0.0470
70 ANGINA PECTORIS 1340 0.0467
71 BLOOD PRESSURE SYSTOLIC DECREASED 211 0.0463
72 CAROTID ARTERY STENOSIS 162 0.0463
73 BLOOD PRESSURE DIASTOLIC DECREASED 340 0.0460
74 DIVERTICULUM 327 0.0460
75 BODY HEIGHT DECREASED 489 0.0457
76 PATENT DUCTUS ARTERIOSUS 181 0.0455
77 RENAL CYST 362 0.0455
78 HYPERLIPIDAEMIA 544 0.0455
79 HEART RATE ABNORMAL 253 0.0453
80 BLOOD PRESSURE SYSTOLIC INCREASED 880 0.0451
81 SLEEP APNOEA SYNDROME 861 0.0451
82 NEPHROPATHY 419 0.0448
83 LEFT VENTRICULAR DYSFUNCTION 300 0.0447
84 HEART RATE IRREGULAR 1011 0.0447
85 INTERNAL HAEMORRHAGE 511 0.0447
86 PERIPHERAL VASCULAR DISORDER 228 0.0442
87 EJECTION FRACTION DECREASED 686 0.0441
88 ARTERIOSCLEROSIS 415 0.0441
89 COMPLETED SUICIDE 3645 0.0437
90 DIVERTICULUM INTESTINAL 191 0.0436
91 ACUTE KIDNEY INJURY 6603 0.0431
92 VENTRICULAR ARRHYTHMIA 157 0.0429
93 HYPERKALAEMIA 1497 0.0426
94 BLOOD PRESSURE INADEQUATELY CONTROLLED 256 0.0425
95 BODY TEMPERATURE DECREASED 418 0.0424
96 DYSPNOEA EXERTIONAL 1599 0.0424
97 RENAL FAILURE 5623 0.0423
98 ARTERIAL OCCLUSIVE DISEASE 332 0.0422
99 INTERNATIONAL NORMALISED RATIO INCREASED 1198 0.0420
100 HIATUS HERNIA 543 0.0419
101 BLOOD MAGNESIUM DECREASED 361 0.0418
102 GLUCOSE TOLERANCE IMPAIRED 243 0.0410
103 HYPERTENSIVE CRISIS 457 0.0410
104 BLOOD TEST ABNORMAL 575 0.0409
105 HYPERVOLAEMIA 202 0.0408
106 CARDIOMEGALY 502 0.0408
107 EXERCISE TOLERANCE DECREASED 234 0.0406
108 GASTROINTESTINAL HAEMORRHAGE 3338 0.0399
109 HAIR DISORDER 329 0.0399
110 BLOOD POTASSIUM INCREASED 645 0.0397
111 GLOMERULAR FILTRATION RATE DECREASED 485 0.0394
112 DIZZINESS POSTURAL 382 0.0394
113 DYSLIPIDAEMIA 200 0.0393
114 RENAL FAILURE CHRONIC 302 0.0392
115 CARDIAC PACEMAKER INSERTION 234 0.0392
116 HYPOTENSION 7871 0.0392
117 BLOOD PRESSURE FLUCTUATION 936 0.0390
118 BLOOD URINE PRESENT 740 0.0389
119 SKIN ABRASION 184 0.0389
120 RALES 226 0.0389
121 PRODUCT PRESCRIBING ERROR 926 0.0388
122 BLOOD CREATINE INCREASED 172 0.0388
123 CARPAL TUNNEL SYNDROME 544 0.0388
124 CARDIAC FAILURE ACUTE 258 0.0387
125 CARDIAC FLUTTER 250 0.0386
126 ELECTROLYTE IMBALANCE 445 0.0383
127 COAGULOPATHY 638 0.0383
128 STENT PLACEMENT 308 0.0382
129 CATHETERISATION CARDIAC 169 0.0381
130 ATELECTASIS 367 0.0379
131 BUNDLE BRANCH BLOCK RIGHT 174 0.0379
132 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 194 0.0378
133 PULSELESS ELECTRICAL ACTIVITY 158 0.0378
134 SPINAL OSTEOARTHRITIS 332 0.0378
135 SPINAL COLUMN STENOSIS 178 0.0376
136 ACUTE RESPIRATORY FAILURE 713 0.0370
137 VENTRICULAR FIBRILLATION 408 0.0367
138 WEIGHT FLUCTUATION 383 0.0366
139 ORTHOSTATIC HYPOTENSION 635 0.0364
140 HAEMORRHAGIC STROKE 283 0.0362
141 PSYCHOLOGICAL TRAUMA 312 0.0361
142 ELECTROCARDIOGRAM ABNORMAL 283 0.0360
143 DIABETIC NEUROPATHY 178 0.0359
144 ATRIAL SEPTAL DEFECT 300 0.0358
145 RENAL FUNCTION TEST ABNORMAL 165 0.0355
146 HAIR COLOUR CHANGES 441 0.0354
147 BLOOD UREA INCREASED 590 0.0352
148 INCREASED TENDENCY TO BRUISE 323 0.0351
149 AORTIC ANEURYSM 267 0.0351
150 HAEMATOMA 909 0.0350
151 SMALL FOR DATES BABY 174 0.0350
152 RENAL TUBULAR NECROSIS 343 0.0349
153 INTERVERTEBRAL DISC DEGENERATION 323 0.0349
154 TUBULOINTERSTITIAL NEPHRITIS 654 0.0349
155 EXTRASYSTOLES 243 0.0348
156 ANEURYSM 173 0.0347
157 PULSE ABSENT 165 0.0347
158 ARRHYTHMIA 1642 0.0346
159 BENIGN PROSTATIC HYPERPLASIA 179 0.0346
160 TORSADE DE POINTES 270 0.0344
161 HYPOMAGNESAEMIA 479 0.0344
162 MYOCARDIAL ISCHAEMIA 391 0.0343
163 HAEMATURIA 1169 0.0341
164 MYOCARDIAL INFARCTION 5942 0.0340
165 MENTAL STATUS CHANGES 945 0.0340
166 SYNCOPE 3403 0.0340
167 ECCHYMOSIS 232 0.0338
168 FLANK PAIN 314 0.0335
169 BLOOD PRESSURE DIASTOLIC INCREASED 154 0.0333
170 ABDOMINAL HERNIA 152 0.0333
171 BLOOD SODIUM DECREASED 625 0.0331
172 IRON DEFICIENCY ANAEMIA 306 0.0331
173 PULMONARY OEDEMA 1483 0.0331
174 CARDIOMYOPATHY 489 0.0331
175 BLOOD POTASSIUM DECREASED 990 0.0329
176 URINE OUTPUT DECREASED 287 0.0328
177 BLOOD PRESSURE INCREASED 5013 0.0328
178 PRESYNCOPE 794 0.0326
179 CLOSTRIDIUM DIFFICILE COLITIS 346 0.0326
180 HAIR TEXTURE ABNORMAL 436 0.0326
181 HAEMATOCRIT DECREASED 645 0.0325
182 UROSEPSIS 300 0.0325
183 RENAL FAILURE ACUTE 1369 0.0322
184 PULMONARY HYPERTENSION 670 0.0321
185 HAEMATOCHEZIA 1775 0.0321
186 BLOOD CREATININE INCREASED 2099 0.0321
187 HYPERKERATOSIS 177 0.0321
188 POLYP 210 0.0320
189 LUNG INFILTRATION 283 0.0320
190 RHABDOMYOLYSIS 1333 0.0319
191 PROTHROMBIN TIME PROLONGED 191 0.0319
192 HEART RATE INCREASED 3161 0.0319
193 BLOOD ALBUMIN DECREASED 253 0.0319
194 MYOPATHY 275 0.0318
195 HYPOKALAEMIA 1469 0.0318
196 RECTAL HAEMORRHAGE 1362 0.0317
197 TRANSIENT ISCHAEMIC ATTACK 1065 0.0315
198 BLOOD IRON DECREASED 374 0.0315
199 HOSPICE CARE 311 0.0315
200 OSTEOARTHRITIS 1333 0.0314
201 SUBDURAL HAEMATOMA 448 0.0313
202 CIRCULATORY COLLAPSE 532 0.0312
203 DEHYDRATION 4161 0.0312
204 IMPAIRED GASTRIC EMPTYING 425 0.0311
205 OEDEMA PERIPHERAL 3791 0.0311
206 ECONOMIC PROBLEM 470 0.0310
207 MELAENA 682 0.0310
208 BLOOD PRESSURE DECREASED 2058 0.0309
209 BLOOD PRESSURE ABNORMAL 615 0.0309
210 PLEURAL EFFUSION 1875 0.0308
211 DRUG INTERACTION 4876 0.0307
212 HAEMODYNAMIC INSTABILITY 234 0.0307
213 CARDIAC DISORDER 2870 0.0306
214 CARDIAC FAILURE 2462 0.0306
215 CARDIAC MURMUR 265 0.0306
216 LACERATION 287 0.0305
217 GENERAL PHYSICAL HEALTH DETERIORATION 3525 0.0304
218 HAEMOGLOBIN DECREASED 3128 0.0304
219 DRUG LEVEL INCREASED 504 0.0304
220 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1587 0.0304
221 NOCTURIA 368 0.0303
222 UNRESPONSIVE TO STIMULI 782 0.0303
223 PULMONARY CONGESTION 398 0.0302
224 GASTRIC ULCER HAEMORRHAGE 167 0.0301
225 BLOOD URIC ACID INCREASED 174 0.0301
226 URINE ODOUR ABNORMAL 177 0.0301
227 POST PROCEDURAL HAEMORRHAGE 348 0.0299
228 ENDOCARDITIS 153 0.0298
229 ULCER HAEMORRHAGE 201 0.0297
230 LARGE INTESTINE POLYP 205 0.0296
231 FAECES DISCOLOURED 639 0.0294
232 HYPERTENSION 6239 0.0294
233 POLYURIA 241 0.0294
234 EPISTAXIS 2201 0.0294
235 MULTIPLE INJURIES 185 0.0294
236 ORAL PAIN 657 0.0293
237 LOCALISED INFECTION 709 0.0293
238 CARDIAC OPERATION 250 0.0291
239 SUBARACHNOID HAEMORRHAGE 295 0.0289
240 PULMONARY MASS 430 0.0288
241 PRE-EXISTING CONDITION IMPROVED 180 0.0288
242 TRANSFUSION 302 0.0288
243 GASTROOESOPHAGEAL REFLUX DISEASE 2318 0.0288
244 FLUID RETENTION 1462 0.0287
245 VITAMIN D DEFICIENCY 280 0.0287
246 METABOLIC ACIDOSIS 916 0.0286
247 CHEST PAIN 5281 0.0285
248 HEPATIC STEATOSIS 530 0.0284
249 PROSTATIC SPECIFIC ANTIGEN INCREASED 391 0.0284
250 FALL 9439 0.0283
251 MADAROSIS 329 0.0283
252 RENAL IMPAIRMENT 2380 0.0283
253 PERICARDIAL EFFUSION 653 0.0282
254 SINUS TACHYCARDIA 400 0.0281
255 ACIDOSIS 215 0.0281
256 CARDIAC ARREST 2322 0.0281
257 FLUID OVERLOAD 409 0.0281
258 SKIN LACERATION 305 0.0280
259 CONTUSION 2691 0.0279
260 ANHEDONIA 728 0.0277
261 MENISCUS INJURY 170 0.0276
262 RIB FRACTURE 568 0.0276
263 LACTIC ACIDOSIS 893 0.0275
264 HYPOXIA 970 0.0275
265 RENAL DISORDER 1279 0.0274
266 INTESTINAL ISCHAEMIA 151 0.0274
267 HYPERTHYROIDISM 397 0.0274
268 DUODENAL ULCER 193 0.0273
269 PELVIC FRACTURE 213 0.0273
270 PURPURA 242 0.0273
271 HAEMORRHAGE INTRACRANIAL 407 0.0272
272 BLOOD CALCIUM DECREASED 306 0.0272
273 ANAEMIA 5182 0.0271
274 FOETAL GROWTH RESTRICTION 165 0.0271
275 DECREASED ACTIVITY 292 0.0270
276 BLOOD COUNT ABNORMAL 409 0.0269
277 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 458 0.0269
278 HAEMOPTYSIS 751 0.0269
279 BASAL CELL CARCINOMA 420 0.0269
280 PERIPHERAL COLDNESS 369 0.0268
281 RED BLOOD CELL COUNT DECREASED 768 0.0268
282 HYPOTHYROIDISM 856 0.0268
283 FULL BLOOD COUNT DECREASED 539 0.0267
284 DIVERTICULITIS 740 0.0267
285 MUSCULOSKELETAL PAIN 1397 0.0266
286 ABNORMAL LOSS OF WEIGHT 181 0.0265
287 DYSURIA 974 0.0264
288 HEAD INJURY 833 0.0263
289 GROIN PAIN 230 0.0262
290 PERIPHERAL SWELLING 4032 0.0261
291 CHOLELITHIASIS 858 0.0261
292 CEREBRAL HAEMORRHAGE 936 0.0261
293 GASTRIC ULCER 495 0.0260
294 LIMB INJURY 705 0.0259
295 DYSPNOEA 14670 0.0259
296 ASTHENIA 9734 0.0259
297 LYMPHOEDEMA 179 0.0259
298 SKIN ULCER 668 0.0258
299 POLLAKIURIA 1077 0.0258
300 WALKING AID USER 170 0.0258
301 SCIATICA 410 0.0257
302 GASTRITIS 676 0.0257
303 HYPONATRAEMIA 1446 0.0256
304 DECUBITUS ULCER 209 0.0256
305 CELLULITIS 1292 0.0256
306 URINARY TRACT INFECTION 4371 0.0256
307 VITAMIN D DECREASED 219 0.0256
308 SMALL INTESTINAL OBSTRUCTION 315 0.0256
309 SHOCK HAEMORRHAGIC 208 0.0255
310 HIP FRACTURE 821 0.0255
311 HAEMORRHOIDS 495 0.0254
312 INGUINAL HERNIA 154 0.0253
313 PLATELET COUNT INCREASED 328 0.0251
314 ROTATOR CUFF SYNDROME 323 0.0251
315 FULL BLOOD COUNT ABNORMAL 266 0.0251
316 NERVE COMPRESSION 232 0.0251
317 EYE HAEMORRHAGE 335 0.0251
318 MUSCULOSKELETAL CHEST PAIN 388 0.0250
319 MACULAR DEGENERATION 299 0.0250
320 HAEMOGLOBIN ABNORMAL 161 0.0250
321 HYPOGLYCAEMIA 1211 0.0249
322 FLUSHING 2529 0.0249
323 ISCHAEMIC STROKE 442 0.0247
324 FIBROMYALGIA 602 0.0247
325 HYPERCHOLESTEROLAEMIA 239 0.0247
326 BLOOD TRIGLYCERIDES INCREASED 437 0.0247
327 CHROMATURIA 558 0.0247
328 CYSTITIS 786 0.0247
329 TOOTH ABSCESS 251 0.0246
330 RESPIRATORY FAILURE 1795 0.0246
331 CATARACT 1460 0.0245
332 FAECES SOFT 178 0.0245
333 PALPITATIONS 2862 0.0244
334 DIZZINESS 12188 0.0244
335 DRUG PRESCRIBING ERROR 469 0.0244
336 PALLOR 663 0.0243
337 PRODUCTIVE COUGH 1163 0.0243
338 OBESITY 388 0.0243
339 HAEMODIALYSIS 204 0.0243
340 OXYGEN SATURATION DECREASED 1362 0.0242
341 HYPOTHERMIA 245 0.0242
342 GINGIVAL BLEEDING 330 0.0241
343 PETECHIAE 252 0.0241
344 OSTEOPENIA 366 0.0241
345 BALANCE DISORDER 2084 0.0241
346 SEASONAL ALLERGY 341 0.0241
347 SPLENOMEGALY 282 0.0240
348 HYPOPHAGIA 615 0.0240
349 OESOPHAGITIS 262 0.0240
350 DEMENTIA 669 0.0239
351 TACHYCARDIA 2126 0.0239
352 BOWEL MOVEMENT IRREGULARITY 183 0.0239
353 FLATULENCE 1354 0.0239
354 CLOSTRIDIUM DIFFICILE INFECTION 521 0.0238
355 WEIGHT DECREASED 6653 0.0238
356 HEMIPARESIS 403 0.0238
357 POOR QUALITY SLEEP 511 0.0237
358 MOUTH HAEMORRHAGE 174 0.0237
359 LEUKOCYTOSIS 429 0.0237
360 HYPERGLYCAEMIA 863 0.0237
361 EXOSTOSIS 216 0.0236
362 DYSSTASIA 690 0.0236
363 INTERVERTEBRAL DISC PROTRUSION 516 0.0236
364 MUSCULAR WEAKNESS 2679 0.0235
365 PULMONARY THROMBOSIS 257 0.0235
366 SHOCK 540 0.0235
367 TASTE DISORDER 476 0.0234
368 DECREASED APPETITE 5424 0.0233
369 ANAL INCONTINENCE 210 0.0233
370 JOINT EFFUSION 160 0.0232
371 INITIAL INSOMNIA 238 0.0232
372 ARTHRITIS 1824 0.0232
373 INCONTINENCE 245 0.0232
374 HALLUCINATION, VISUAL 488 0.0231
375 AGEUSIA 576 0.0231
376 SEPSIS 2575 0.0231
377 MUSCLE STRAIN 199 0.0230
378 POSTOPERATIVE WOUND INFECTION 155 0.0229
379 OSTEOPOROSIS 940 0.0228
380 DIABETES MELLITUS INADEQUATE CONTROL 404 0.0228
381 PNEUMONIA 7385 0.0228
382 HAEMATEMESIS 577 0.0227
383 BLOOD DISORDER 182 0.0227
384 RIGHT VENTRICULAR FAILURE 159 0.0227
385 WOUND 634 0.0227
386 TOOTH INFECTION 299 0.0227
387 DELIRIUM 787 0.0227
388 WHITE BLOOD CELL COUNT INCREASED 870 0.0227
389 HYPOTONIA 226 0.0226
390 GENERALISED OEDEMA 280 0.0226
391 MULTI-ORGAN FAILURE 391 0.0226
392 RETCHING 480 0.0225
393 OEDEMA 1219 0.0225
394 DYSPHONIA 1312 0.0224
395 EMPHYSEMA 226 0.0224
396 COUGH 6274 0.0223
397 CONSTIPATION 4879 0.0223
398 URINARY RETENTION 746 0.0223
399 BURSITIS 271 0.0223
400 CHEST DISCOMFORT 2286 0.0223
401 DYSPEPSIA 2196 0.0223
402 GAIT DISTURBANCE 4261 0.0222
403 UPPER-AIRWAY COUGH SYNDROME 183 0.0222
404 URINARY INCONTINENCE 658 0.0222
405 HEPATOMEGALY 218 0.0222
406 BRONCHITIS 1642 0.0222
407 TOOTH FRACTURE 244 0.0221
408 DIARRHOEA 14271 0.0221
409 CARDIO-RESPIRATORY ARREST 924 0.0221
410 TOOTH DISORDER 490 0.0220
411 HYPOCALCAEMIA 417 0.0220
412 WHEEZING 1306 0.0220
413 ERUCTATION 426 0.0220
414 SPINAL COMPRESSION FRACTURE 182 0.0220
415 TACHYPNOEA 298 0.0219
416 ASPIRATION 240 0.0219
417 CEREBROVASCULAR ACCIDENT 3700 0.0218
418 BACK DISORDER 355 0.0218
419 HYPERSOMNIA 625 0.0218
420 MUSCULOSKELETAL DISCOMFORT 375 0.0218
421 ENCEPHALOPATHY 533 0.0217
422 JOINT RANGE OF MOTION DECREASED 291 0.0217
423 TYPE 2 DIABETES MELLITUS 730 0.0217
424 TOXICITY TO VARIOUS AGENTS 3655 0.0217
425 SQUAMOUS CELL CARCINOMA 204 0.0216
426 EATING DISORDER 461 0.0216
427 MALNUTRITION 242 0.0216
428 RESPIRATORY RATE INCREASED 192 0.0216
429 MICTURITION URGENCY 247 0.0216
430 ABNORMAL FAECES 177 0.0216
431 BONE DISORDER 392 0.0215
432 DIALYSIS 305 0.0215
433 FATIGUE 16706 0.0214
434 THROMBOSIS 1726 0.0214
435 WRIST FRACTURE 257 0.0214
436 COVID-19 PNEUMONIA 253 0.0214
437 GINGIVAL PAIN 170 0.0213
438 POST PROCEDURAL COMPLICATION 410 0.0213
439 COLD SWEAT 376 0.0213
440 POLYNEUROPATHY 255 0.0213
441 CONFUSIONAL STATE 3442 0.0213
442 PLATELET COUNT DECREASED 2266 0.0212
443 FOOT FRACTURE 403 0.0212
444 NEPHROLITHIASIS 974 0.0212
445 SCAB 242 0.0212
446 BLOOD CALCIUM INCREASED 186 0.0212
447 LOW DENSITY LIPOPROTEIN INCREASED 164 0.0212
448 UPPER LIMB FRACTURE 421 0.0211
449 FACIAL PAIN 188 0.0210
450 EAR DISCOMFORT 216 0.0210
451 STAPHYLOCOCCAL INFECTION 694 0.0210
452 GASTROENTERITIS 307 0.0210
453 ANURIA 181 0.0210
454 BLOOD CHOLESTEROL INCREASED 980 0.0210
455 NEURALGIA 511 0.0210
456 HALLUCINATION 1577 0.0209
457 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1005 0.0209
458 DENTAL CARIES 231 0.0209
459 BACK PAIN 4845 0.0208
460 CONTRAINDICATED PRODUCT ADMINISTERED 631 0.0208
461 TENDERNESS 217 0.0208
462 FEELING HOT 1272 0.0207
463 LIGAMENT SPRAIN 205 0.0207
464 ELECTROCARDIOGRAM QT PROLONGED 745 0.0207
465 RENAL PAIN 219 0.0206
466 BLINDNESS TRANSIENT 152 0.0206
467 SKIN HAEMORRHAGE 305 0.0206
468 DRY MOUTH 1669 0.0205
469 RESTLESS LEGS SYNDROME 374 0.0205
470 PAIN IN EXTREMITY 6039 0.0205
471 SKIN DISCOLOURATION 939 0.0204
472 LIMB DISCOMFORT 632 0.0204
473 HYPOKINESIA 296 0.0204
474 DYSARTHRIA 767 0.0204
475 MUSCLE ATROPHY 258 0.0203
476 ADRENAL INSUFFICIENCY 247 0.0203
477 SINUS CONGESTION 275 0.0203
478 SPUTUM DISCOLOURED 193 0.0203
479 BLADDER DISORDER 202 0.0203
480 HERNIA 393 0.0203
481 CHOLECYSTITIS 242 0.0203
482 FEAR 546 0.0203
483 SLUGGISHNESS 207 0.0203
484 IMPAIRED QUALITY OF LIFE 291 0.0202
485 APHASIA 611 0.0202
486 LETHARGY 1164 0.0202
487 SPINAL PAIN 237 0.0202
488 RHINORRHOEA 1303 0.0201
489 VITREOUS FLOATERS 198 0.0201
490 BACK INJURY 219 0.0201
491 DISORIENTATION 798 0.0201
492 TOOTHACHE 364 0.0201
493 LOSS OF CONSCIOUSNESS 2571 0.0200
494 DIABETES MELLITUS 1529 0.0200
495 SINUS DISORDER 396 0.0200
496 NERVE INJURY 222 0.0199
497 BURNING SENSATION 1398 0.0199
498 HOT FLUSH 1495 0.0198
499 MASS 277 0.0198
500 CONCUSSION 153 0.0197
501 LOW BIRTH WEIGHT BABY 157 0.0197
502 BACTERAEMIA 234 0.0197
503 HYPERHIDROSIS 2538 0.0197
504 OSTEOMYELITIS 356 0.0196
505 ABDOMINAL PAIN UPPER 4046 0.0196
506 UPPER RESPIRATORY TRACT INFECTION 908 0.0196
507 PARKINSONISM 191 0.0196
508 FOOT DEFORMITY 217 0.0196
509 FEELING COLD 544 0.0195
510 MULTIPLE ALLERGIES 153 0.0195
511 JOINT DISLOCATION 206 0.0195
512 NECK PAIN 1089 0.0195
513 DEEP VEIN THROMBOSIS 1266 0.0195
514 HYPOACUSIS 838 0.0194
515 NIGHT SWEATS 626 0.0194
516 DEPRESSED LEVEL OF CONSCIOUSNESS 768 0.0194
517 GASTROENTERITIS VIRAL 350 0.0194
518 DYSGEUSIA 1437 0.0193
519 ABDOMINAL DISCOMFORT 3238 0.0193
520 GASTROINTESTINAL INFECTION 173 0.0193
521 DRY THROAT 196 0.0193
522 RESPIRATORY ARREST 531 0.0192
523 KIDNEY INFECTION 378 0.0192
524 ANKLE FRACTURE 298 0.0192
525 DYSPHAGIA 1819 0.0191
526 SCRATCH 202 0.0191
527 THYROID DISORDER 295 0.0191
528 RESPIRATORY TRACT CONGESTION 304 0.0191
529 EYE INFECTION 216 0.0191
530 MIDDLE INSOMNIA 356 0.0190
531 HICCUPS 156 0.0190
532 STOMATITIS 1152 0.0190
533 WOUND INFECTION 208 0.0190
534 SKIN CANCER 408 0.0189
535 BLINDNESS UNILATERAL 267 0.0189
536 SPINAL DISORDER 179 0.0189
537 EAR PAIN 367 0.0189
538 CANDIDA INFECTION 318 0.0188
539 ABDOMINAL PAIN LOWER 476 0.0188
540 JOINT INJURY 402 0.0188
541 HYPERCALCAEMIA 232 0.0188
542 GLAUCOMA 361 0.0187
543 GLYCOSYLATED HAEMOGLOBIN INCREASED 473 0.0187
544 NEUROPATHY PERIPHERAL 1779 0.0187
545 DELUSION 290 0.0186
546 PRODUCT ADMINISTRATION ERROR 377 0.0186
547 HEAD DISCOMFORT 330 0.0186
548 BLOOD CREATINE PHOSPHOKINASE INCREASED 536 0.0186
549 PNEUMONIA ASPIRATION 465 0.0186
550 MUSCLE SPASMS 3409 0.0186
551 LIVER FUNCTION TEST ABNORMAL 540 0.0185
552 GASTROINTESTINAL PAIN 204 0.0185
553 CYST 230 0.0185
554 BODY TEMPERATURE INCREASED 378 0.0185
555 MEMORY IMPAIRMENT 2544 0.0185
556 ORAL DISCOMFORT 257 0.0185
557 BLOOD ALKALINE PHOSPHATASE INCREASED 459 0.0185
558 ABDOMINAL PAIN 4295 0.0184
559 RESPIRATORY DISTRESS 509 0.0184
560 IMPAIRED HEALING 605 0.0184
561 LOCAL SWELLING 321 0.0184
562 MYALGIA 3124 0.0184
563 PRESCRIBED UNDERDOSE 366 0.0183
564 PANCYTOPENIA 1025 0.0183
565 SKIN LESION 503 0.0183
566 QUALITY OF LIFE DECREASED 246 0.0183
567 FRACTURE 347 0.0183
568 NODULE 239 0.0183
569 GAIT INABILITY 609 0.0182
570 PAIN IN JAW 516 0.0182
571 ABDOMINAL DISTENSION 1895 0.0181
572 NEUTROPHIL COUNT INCREASED 185 0.0180
573 HAEMORRHAGE 1888 0.0180
574 ULCER 287 0.0180
575 ILEUS 224 0.0180
576 BLOOD GLUCOSE DECREASED 865 0.0180
577 INFLUENZA 2007 0.0180
578 HERPES ZOSTER 1033 0.0180
579 PNEUMONITIS 488 0.0179
580 SKIN DISORDER 597 0.0179
581 MUSCLE TIGHTNESS 289 0.0178
582 BLOOD THYROID STIMULATING HORMONE INCREASED 164 0.0178
583 SCAR 305 0.0178
584 PULMONARY ARTERIAL HYPERTENSION 258 0.0178
585 LABORATORY TEST ABNORMAL 525 0.0178
586 CEREBRAL INFARCTION 434 0.0177
587 DIPLOPIA 461 0.0177
588 NAUSEA 14029 0.0177
589 CHOKING 344 0.0176
590 OROPHARYNGEAL PAIN 1631 0.0176
591 JOINT STIFFNESS 462 0.0176
592 MYOSITIS 158 0.0176
593 GASTRIC DISORDER 602 0.0175
594 WEIGHT INCREASED 3924 0.0175
595 MOBILITY DECREASED 1258 0.0175
596 CHILLS 2049 0.0175
597 ATAXIA 207 0.0174
598 VASCULITIS 203 0.0174
599 SPINAL FRACTURE 349 0.0174
600 INSOMNIA 4638 0.0174
601 MEDICATION ERROR 965 0.0173
602 GASTRIC HAEMORRHAGE 199 0.0173
603 THIRST 309 0.0173
604 NASAL CONGESTION 1015 0.0173
605 ANGIOEDEMA 763 0.0172
606 ABSCESS 275 0.0172
607 JOINT SWELLING 2078 0.0172
608 GALLBLADDER DISORDER 307 0.0172
609 ASCITES 505 0.0172
610 ACTIVITIES OF DAILY LIVING IMPAIRED 340 0.0172
611 VERTIGO 1043 0.0171
612 PRODUCT DOSE OMISSION 1116 0.0171
613 TREMOR 2834 0.0171
614 BLOOD GLUCOSE FLUCTUATION 187 0.0170
615 BONE PAIN 999 0.0170
616 ARTHRALGIA 7089 0.0170
617 PANCREATITIS 901 0.0170
618 SWOLLEN TONGUE 532 0.0170
619 VISION BLURRED 2334 0.0170
620 ERECTILE DYSFUNCTION 436 0.0170
621 SEPTIC SHOCK 736 0.0169
622 APHONIA 235 0.0168
623 PREMATURE DELIVERY 268 0.0168
624 BLOOD GLUCOSE INCREASED 3152 0.0167
625 BRAIN OEDEMA 211 0.0167
626 PNEUMOTHORAX 264 0.0166
627 TINNITUS 764 0.0166
628 BLOOD GLUCOSE ABNORMAL 306 0.0166
629 PARAESTHESIA 2606 0.0165
630 RESTLESSNESS 606 0.0165
631 RESPIRATORY TRACT INFECTION 431 0.0165
632 TREATMENT NONCOMPLIANCE 905 0.0165
633 INCREASED APPETITE 316 0.0165
634 MULTIPLE ORGAN DYSFUNCTION SYNDROME 468 0.0165
635 HYPOAESTHESIA 2469 0.0165
636 TRANSAMINASES INCREASED 366 0.0164
637 PLASMA CELL MYELOMA 640 0.0164
638 FREQUENT BOWEL MOVEMENTS 443 0.0164
639 AMNESIA 1065 0.0164
640 MUSCULOSKELETAL STIFFNESS 1434 0.0164
641 BLOOD BILIRUBIN INCREASED 442 0.0163
642 LUNG INFECTION 254 0.0163
643 SWELLING 1529 0.0163
644 ORAL CANDIDIASIS 215 0.0163
645 INTENTIONAL PRODUCT USE ISSUE 1428 0.0163
646 SEROTONIN SYNDROME 313 0.0163
647 SOMNOLENCE 3277 0.0163
648 FEEDING DISORDER 330 0.0163
649 ANXIETY 4630 0.0163
650 WHITE BLOOD CELL COUNT DECREASED 1763 0.0162
651 RASH PRURITIC 881 0.0162
652 PULMONARY EMBOLISM 1542 0.0162
653 MOTOR DYSFUNCTION 165 0.0162
654 PRURITUS GENERALISED 350 0.0162
655 SPEECH DISORDER 848 0.0162
656 PULMONARY FIBROSIS 310 0.0161
657 COGNITIVE DISORDER 752 0.0161
658 NERVOUSNESS 840 0.0161
659 FEELING ABNORMAL 3849 0.0160
660 INTESTINAL OBSTRUCTION 605 0.0160
661 PROTEINURIA 305 0.0160
662 THROAT IRRITATION 716 0.0159
663 SINUSITIS 1635 0.0159
664 BREAST PAIN 170 0.0159
665 NASOPHARYNGITIS 2934 0.0159
666 INABILITY TO AFFORD MEDICATION 158 0.0159
667 VOMITING 7478 0.0159
668 METASTASES TO BONE 261 0.0159
669 ALOPECIA 3122 0.0159
670 ABASIA 392 0.0158
671 COVID-19 2781 0.0158
672 FEELING JITTERY 302 0.0158
673 MYOCARDITIS 181 0.0158
674 MYOCLONUS 188 0.0157
675 SNEEZING 353 0.0157
676 PARAESTHESIA ORAL 227 0.0157
677 BACTERIAL INFECTION 293 0.0157
678 VISUAL IMPAIRMENT 1945 0.0157
679 HEPATIC ENZYME INCREASED 1069 0.0157
680 DEPRESSION 3567 0.0157
681 LACRIMATION INCREASED 472 0.0156
682 LIP SWELLING 520 0.0156
683 BLISTER 876 0.0156
684 THERAPY CHANGE 153 0.0155
685 SLEEP DISORDER 1098 0.0155
686 LIVER FUNCTION TEST INCREASED 334 0.0155
687 MYELODYSPLASTIC SYNDROME 225 0.0155
688 ARTHROPATHY 864 0.0155
689 UNEVALUABLE EVENT 1176 0.0155
690 METASTASES TO LIVER 273 0.0155
691 HYPOAESTHESIA ORAL 234 0.0155
692 THROMBOCYTOPENIA 1730 0.0155
693 PRODUCT ODOUR ABNORMAL 162 0.0155
694 PHARYNGEAL OEDEMA 237 0.0154
695 LUNG DISORDER 755 0.0154
696 MALIGNANT MELANOMA 206 0.0154
697 BEDRIDDEN 202 0.0154
698 TOOTH EXTRACTION 191 0.0153
699 KNEE ARTHROPLASTY 323 0.0153
700 SECRETION DISCHARGE 192 0.0153
701 PAIN 9416 0.0153
702 PREMATURE BABY 460 0.0153
703 POISONING 192 0.0153
704 INTENTIONAL OVERDOSE 980 0.0153
705 ASPARTATE AMINOTRANSFERASE INCREASED 811 0.0153
706 THERAPY CESSATION 781 0.0152
707 EYE PAIN 858 0.0152
708 RASH MACULAR 530 0.0151
709 CHOLECYSTECTOMY 173 0.0151
710 NEOPLASM 174 0.0151
711 MALAISE 6630 0.0151
712 ALANINE AMINOTRANSFERASE INCREASED 928 0.0151
713 RESPIRATORY DISORDER 451 0.0151
714 ACUTE HEPATIC FAILURE 206 0.0151
715 FUNGAL INFECTION 502 0.0150
716 SUDDEN DEATH 159 0.0150
717 GAMMA-GLUTAMYLTRANSFERASE INCREASED 333 0.0150
718 CARDIOVASCULAR DISORDER 381 0.0150
719 ACUTE RESPIRATORY DISTRESS SYNDROME 265 0.0150
720 PANCREATITIS ACUTE 336 0.0149
721 IMMUNE SYSTEM DISORDER 197 0.0149
722 TEMPERATURE INTOLERANCE 154 0.0149
723 CONDITION AGGRAVATED 4530 0.0149
724 PHOTOSENSITIVITY REACTION 246 0.0149
725 ABNORMAL DREAMS 411 0.0149
726 SPINAL OPERATION 183 0.0148
727 COLITIS 563 0.0148
728 RESPIRATORY DEPRESSION 182 0.0148
729 PRODUCT TASTE ABNORMAL 201 0.0148
730 SKIN INFECTION 166 0.0148
731 HEADACHE 9256 0.0147
732 MOVEMENT DISORDER 473 0.0147
733 NIGHTMARE 509 0.0147
734 POOR VENOUS ACCESS 151 0.0146
735 PRURITUS 5586 0.0145
736 INSURANCE ISSUE 222 0.0145
737 VIRAL INFECTION 483 0.0145
738 EYE DISORDER 476 0.0145
739 DRUG-INDUCED LIVER INJURY 454 0.0145
740 METASTASES TO LUNG 167 0.0144
741 DEVICE RELATED INFECTION 222 0.0144
742 HEPATIC CIRRHOSIS 271 0.0144
743 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1025 0.0144
744 CYANOSIS 226 0.0144
745 IMPAIRED DRIVING ABILITY 163 0.0143
746 INTENTIONAL PRODUCT MISUSE 1254 0.0143
747 LOWER LIMB FRACTURE 274 0.0142
748 INJURY 998 0.0142
749 PHARYNGITIS 176 0.0142
750 DERMATITIS CONTACT 161 0.0141
751 LEUKOPENIA 706 0.0141
752 DISEASE RECURRENCE 670 0.0141
753 MUSCULOSKELETAL DISORDER 268 0.0141
754 PANIC ATTACK 513 0.0141
755 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 767 0.0140
756 HIP ARTHROPLASTY 214 0.0140
757 TENDON RUPTURE 172 0.0139
758 LYMPHADENOPATHY 493 0.0139
759 BRAIN FOG 218 0.0139
760 BLOOD LACTATE DEHYDROGENASE INCREASED 220 0.0139
761 EAR INFECTION 369 0.0139
762 HEPATIC FAILURE 418 0.0139
763 TENDONITIS 214 0.0138
764 INFLAMMATION 711 0.0138
765 THERAPY INTERRUPTED 984 0.0138
766 DEAFNESS 360 0.0138
767 SWELLING FACE 896 0.0137
768 THERAPEUTIC RESPONSE UNEXPECTED 616 0.0137
769 PHOTOPHOBIA 258 0.0137
770 THINKING ABNORMAL 255 0.0137
771 PYREXIA 4722 0.0136
772 INFECTION 1970 0.0136
773 DISCOMFORT 828 0.0136
774 COLON CANCER 202 0.0135
775 DRUG DOSE OMISSION 2237 0.0135
776 JAUNDICE 364 0.0135
777 MUSCLE RIGIDITY 161 0.0134
778 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 957 0.0134
779 PRODUCT DOSE OMISSION IN ERROR 379 0.0134
780 VISUAL ACUITY REDUCED 444 0.0134
781 DRUG TOXICITY 182 0.0133
782 RASH PAPULAR 299 0.0133
783 COORDINATION ABNORMAL 186 0.0133
784 SENSORY DISTURBANCE 214 0.0133
785 DRY EYE 664 0.0133
786 PRODUCT USE COMPLAINT 209 0.0133
787 DISTURBANCE IN ATTENTION 714 0.0132
788 APATHY 193 0.0132
789 GASTROINTESTINAL DISORDER 1184 0.0132
790 INJECTION SITE EXTRAVASATION 163 0.0132
791 PROCEDURAL PAIN 366 0.0132
792 INFUSION SITE PAIN 170 0.0132
793 MENTAL IMPAIRMENT 318 0.0131
794 PRODUCT PHYSICAL ISSUE 264 0.0131
795 WRONG TECHNIQUE IN DRUG USAGE PROCESS 475 0.0131
796 DRUG INTOLERANCE 1260 0.0130
797 GLOSSODYNIA 292 0.0130
798 DISEASE PROGRESSION 1540 0.0130
799 PRODUCT SUBSTITUTION ISSUE 749 0.0130
800 RASH 5653 0.0130
801 BLINDNESS 528 0.0129
802 DYSKINESIA 526 0.0129
803 MUSCLE TWITCHING 298 0.0129
804 DIABETIC KETOACIDOSIS 310 0.0129
805 DEPRESSED MOOD 681 0.0129
806 FEBRILE NEUTROPENIA 852 0.0128
807 HOSPITALISATION 1971 0.0128
808 CYTOPENIA 157 0.0128
809 ALTERED STATE OF CONSCIOUSNESS 277 0.0128
810 PSORIATIC ARTHROPATHY 518 0.0127
811 ILLNESS 1313 0.0127
812 SKIN FISSURES 249 0.0127
813 PARALYSIS 182 0.0127
814 EYE SWELLING 471 0.0126
815 ORAL HERPES 247 0.0126
816 INTENTIONAL DOSE OMISSION 360 0.0126
817 LYMPHOCYTE COUNT DECREASED 223 0.0126
818 AGITATION 926 0.0126
819 ASTHMA 1423 0.0126
820 SARS-COV-2 TEST POSITIVE 166 0.0126
821 INCORRECT PRODUCT ADMINISTRATION DURATION 272 0.0125
822 LIVER DISORDER 556 0.0125
823 COMA 595 0.0125
824 C-REACTIVE PROTEIN INCREASED 454 0.0125
825 ROAD TRAFFIC ACCIDENT 521 0.0124
826 IMMUNODEFICIENCY 185 0.0124
827 RASH GENERALISED 320 0.0123
828 THROAT TIGHTNESS 334 0.0123
829 FEMUR FRACTURE 381 0.0123
830 PARANOIA 212 0.0123
831 SEDATION 322 0.0123
832 HEPATOTOXICITY 273 0.0122
833 PSORIASIS 1601 0.0122
834 FOETAL EXPOSURE DURING PREGNANCY 989 0.0122
835 DRUG EFFECT INCOMPLETE 441 0.0121
836 BRONCHOSPASM 173 0.0121
837 RHEUMATOID ARTHRITIS 1373 0.0121
838 EXPIRED PRODUCT ADMINISTERED 400 0.0120
839 PERICARDITIS 202 0.0120
840 PRODUCT AVAILABILITY ISSUE 273 0.0120
841 OFF LABEL USE 10480 0.0120
842 PRODUCT QUALITY ISSUE 1622 0.0119
843 DRUG ADMINISTRATION ERROR 365 0.0119
844 PERITONITIS 246 0.0119
845 IRRITABLE BOWEL SYNDROME 254 0.0118
846 SUICIDE ATTEMPT 717 0.0118
847 INTRAOCULAR PRESSURE INCREASED 151 0.0118
848 MULTIPLE FRACTURES 194 0.0118
849 IMPAIRED WORK ABILITY 252 0.0118
850 DEATH 10132 0.0117
851 OCULAR HYPERAEMIA 558 0.0117
852 INFLUENZA LIKE ILLNESS 965 0.0117
853 RASH ERYTHEMATOUS 560 0.0117
854 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 273 0.0117
855 DEVICE OCCLUSION 164 0.0116
856 ACUTE MYELOID LEUKAEMIA 181 0.0116
857 PRODUCT USE ISSUE 2181 0.0116
858 INFUSION RELATED REACTION 768 0.0116
859 ERYTHEMA 2372 0.0115
860 MOUTH ULCERATION 242 0.0115
861 SKIN EXFOLIATION 968 0.0115
862 INCORRECT DRUG ADMINISTRATION DURATION 322 0.0114
863 NEOPLASM PROGRESSION 398 0.0114
864 INTENTIONAL DRUG MISUSE 239 0.0114
865 SEIZURE 1320 0.0114
866 DRUG DISPENSING ERROR 174 0.0114
867 THERAPEUTIC PRODUCT EFFECT DECREASED 509 0.0114
868 EYE PRURITUS 380 0.0113
869 OSTEONECROSIS OF JAW 279 0.0113
870 ACCIDENTAL OVERDOSE 412 0.0113
871 PRODUCT DOSE OMISSION ISSUE 3306 0.0112
872 MENTAL DISORDER 489 0.0112
873 PRESCRIBED OVERDOSE 216 0.0112
874 INJECTION SITE MASS 410 0.0111
875 EYE IRRITATION 637 0.0111
876 DISSEMINATED INTRAVASCULAR COAGULATION 155 0.0110
877 ANOSMIA 159 0.0110
878 MALIGNANT NEOPLASM PROGRESSION 1124 0.0110
879 THERAPY NON-RESPONDER 492 0.0109
880 SURGERY 637 0.0109
881 TOXIC EPIDERMAL NECROLYSIS 164 0.0108
882 PRODUCT DISPENSING ERROR 234 0.0107
883 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1934 0.0107
884 DRUG EFFECT DECREASED 576 0.0107
885 DERMATITIS 224 0.0107
886 NEEDLE ISSUE 311 0.0107
887 LUNG NEOPLASM MALIGNANT 437 0.0106
888 HYPERSENSITIVITY 1969 0.0106
889 PRODUCT PRESCRIBING ISSUE 231 0.0106
890 EMOTIONAL DISTRESS 1278 0.0105
891 HALLUCINATION, AUDITORY 167 0.0105
892 LYMPHOMA 162 0.0105
893 FACE OEDEMA 176 0.0104
894 LIVER INJURY 256 0.0104
895 CONJUNCTIVITIS 193 0.0104
896 GENERALISED TONIC-CLONIC SEIZURE 172 0.0104
897 PAIN OF SKIN 279 0.0104
898 UNDERDOSE 756 0.0103
899 URTICARIA 1701 0.0101
900 MIGRAINE 969 0.0101
901 MUCOSAL INFLAMMATION 265 0.0101
902 ADVERSE EVENT 925 0.0100
903 EMOTIONAL DISORDER 309 0.0100
904 DRUG INEFFECTIVE 13111 0.0099
905 CONVULSION 566 0.0099
906 ADVERSE DRUG REACTION 888 0.0099
907 PRODUCT USE IN UNAPPROVED INDICATION 2450 0.0099
908 DRY SKIN 1319 0.0099
909 NERVOUS SYSTEM DISORDER 308 0.0099
910 BONE DENSITY DECREASED 309 0.0099
911 DISABILITY 192 0.0097
912 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1964 0.0097
913 STEVENS-JOHNSON SYNDROME 215 0.0097
914 NEUROTOXICITY 169 0.0096
915 INCORRECT DOSE ADMINISTERED 2201 0.0096
916 CHOLESTASIS 184 0.0096
917 CRYING 347 0.0095
918 PSYCHOTIC DISORDER 281 0.0095
919 ILL-DEFINED DISORDER 577 0.0095
920 NEUTROPHIL COUNT DECREASED 386 0.0095
921 NEOPLASM MALIGNANT 628 0.0094
922 HEPATITIS 235 0.0092
923 TOOTH LOSS 189 0.0091
924 NEUTROPENIA 1235 0.0091
925 DRUG ERUPTION 159 0.0090
926 MOOD ALTERED 244 0.0089
927 WITHDRAWAL SYNDROME 374 0.0089
928 INJECTION SITE BRUISING 709 0.0089
929 INJECTION SITE HAEMORRHAGE 700 0.0088
930 ANGER 294 0.0087
931 ABNORMAL BEHAVIOUR 342 0.0086
932 VAGINAL HAEMORRHAGE 369 0.0085
933 INTERSTITIAL LUNG DISEASE 409 0.0084
934 OVERDOSE 1821 0.0084
935 AGGRESSION 418 0.0083
936 COLITIS ULCERATIVE 373 0.0083
937 CYTOKINE RELEASE SYNDROME 167 0.0083
938 DEVICE MALFUNCTION 584 0.0083
939 THERAPEUTIC RESPONSE DECREASED 503 0.0083
940 EXPOSURE DURING PREGNANCY 511 0.0082
941 APPLICATION SITE PRURITUS 186 0.0082
942 LOWER RESPIRATORY TRACT INFECTION 372 0.0082
943 IRRITABILITY 490 0.0081
944 DEVICE DELIVERY SYSTEM ISSUE 220 0.0080
945 EXTRA DOSE ADMINISTERED 325 0.0080
946 APPLICATION SITE ERYTHEMA 210 0.0080
947 MOOD SWINGS 254 0.0080
948 APPLICATION SITE PAIN 173 0.0078
949 SUICIDAL IDEATION 692 0.0076
950 ECZEMA 395 0.0075
951 BONE MARROW FAILURE 153 0.0075
952 PANCREATIC CARCINOMA 217 0.0075
953 RASH MACULO-PAPULAR 164 0.0074
954 ANAPHYLACTIC REACTION 407 0.0074
955 MATERNAL EXPOSURE DURING PREGNANCY 656 0.0074
956 DEVICE ISSUE 660 0.0074
957 THERAPEUTIC RESPONSE SHORTENED 244 0.0074
958 MULTIPLE SCLEROSIS 349 0.0073
959 INJECTION SITE PRURITUS 484 0.0072
960 INJECTION SITE PAIN 2168 0.0071
961 EPILEPSY 214 0.0070
962 MULTIPLE SCLEROSIS RELAPSE 475 0.0069
963 INJECTION SITE RASH 206 0.0067
964 OSTEONECROSIS 219 0.0067
965 PRODUCT ADHESION ISSUE 236 0.0066
966 HEPATIC FUNCTION ABNORMAL 246 0.0066
967 INJECTION SITE ERYTHEMA 801 0.0065
968 SKIN BURNING SENSATION 459 0.0064
969 INJECTION SITE REACTION 440 0.0064
970 SYSTEMIC LUPUS ERYTHEMATOSUS 226 0.0064
971 INJECTION SITE SWELLING 479 0.0062
972 ANAPHYLACTIC SHOCK 161 0.0062
973 SKIN IRRITATION 280 0.0061
974 TARDIVE DYSKINESIA 172 0.0061
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 195 0.0058
976 TREATMENT FAILURE 450 0.0054
977 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 228 0.0049
978 INCORRECT ROUTE OF DRUG ADMINISTRATION 171 0.0048
979 NO ADVERSE EVENT 864 0.0048
980 PROSTATE CANCER 379 0.0047
981 ACNE 354 0.0047
982 DEVICE DISLOCATION 193 0.0044
983 DRUG ABUSE 368 0.0044
984 DEVICE LEAKAGE 190 0.0044
985 BREAST CANCER 391 0.0042
986 DRUG WITHDRAWAL SYNDROME 367 0.0042
987 ACCIDENTAL EXPOSURE TO PRODUCT 429 0.0042
988 DRUG DOSE OMISSION BY DEVICE 317 0.0040
989 DERMATITIS ATOPIC 207 0.0039
990 PRODUCT STORAGE ERROR 326 0.0037
991 BLADDER CANCER 205 0.0035
992 RENAL CANCER 156 0.0033
993 DEVICE DIFFICULT TO USE 193 0.0029
994 DRUG DEPENDENCE 314 0.0020